CORTNasdaqPharmaceutical PreparationsFiscal year ends December 31
CORCEPT THERAPEUTICS INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 29, 2026
$112.10+1.94 (+1.76%)
Close on Oct 19, 2026
- Market cap
- $13.27B
- P/E (TTM)
- 266.9
- Dividend yield
- –
SEC filings
40 of Corcept Therapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Sep 22, 2026 | Sep 23, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Jul 29, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 29, 2026 | Jul 29, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 17, 2026 | Jun 17, 2026 | SEC EDGAR |
| Current report | 8-K | May 19, 2026 | Jun 3, 2026 | SEC EDGAR |
| Current report | 8-K | May 21, 2026 | May 28, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | Apr 30, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 30, 2026 | Apr 30, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Apr 17, 2026 | Apr 17, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 25, 2026 | Mar 25, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Feb 24, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 24, 2026 | Feb 24, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 19, 2026 | Feb 19, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 22, 2026 | Jan 22, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 31, 2025 | Dec 31, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 4, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 4, 2025 | Nov 4, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 10, 2025 | Oct 14, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 6, 2025 | Oct 6, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 10, 2025 | Sep 10, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Jul 31, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 31, 2025 | Jul 31, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 14, 2025 | Jul 14, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 10, 2025 | Jun 16, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 5, 2025 | SEC EDGAR |
| Current report | 8-K | May 5, 2025 | May 5, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Apr 25, 2025 | Apr 25, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 31, 2025 | Mar 31, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 3, 2025 | Mar 3, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Feb 26, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 26, 2025 | Feb 26, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 30, 2024 | Dec 30, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Oct 30, 2024 | SEC EDGAR |
| Current report | 8-K | Oct 30, 2024 | Oct 30, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Jul 29, 2024 | SEC EDGAR |
| Current report | 8-K | Jul 29, 2024 | Jul 29, 2024 | SEC EDGAR |
| Current report | 8-K | May 17, 2024 | May 23, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2024 | May 1, 2024 | SEC EDGAR |
| Current report | 8-K | May 1, 2024 | May 1, 2024 | SEC EDGAR |
| Current report | 8-K | Apr 12, 2024 | Apr 17, 2024 | SEC EDGAR |